Partnerships are fundamental to our business

We develop strategic partnerships and collaborations with companies and organisations to unlock the full potential value of our products and research pipeline.

Examples of our current partnerships are:

  • Research collaborations with a number of world-class universities and institutions;
  • A clinical collaboration with global pharmaceutical company MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA) to evaluate use of our oncology drug tigilanol tiglate in combination with their immune checkpoint inhibitor Keytruda®; and,
  • A partnership agreement with global specialist animal health company Virbac for the marketing and distribution of our oncology drug (trade name STELFONTA®) as a treatment for canine mast cell tumours.

If you are interested in exploring opportunities for partnerships or collaborations with QBiotics, please contact us partners@qbiotics.com.